Identification of neonatal hearing impairment: Evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance

Citation
Sj. Norton et al., Identification of neonatal hearing impairment: Evaluation of transient evoked otoacoustic emission, distortion product otoacoustic emission, and auditory brain stem response test performance, EAR HEAR, 21(5), 2000, pp. 508-528
Citations number
46
Categorie Soggetti
Otolaryngology
Journal title
EAR AND HEARING
ISSN journal
01960202 → ACNP
Volume
21
Issue
5
Year of publication
2000
Pages
508 - 528
Database
ISI
SICI code
0196-0202(200010)21:5<508:IONHIE>2.0.ZU;2-1
Abstract
Objectives: The purpose of this study was to compare the performance of tra nsient evoked otoacoustic emissions (TEOAEs), distortion product otoacousti c emissions (DPOAEs), and auditory brain stem responses (ABRs) as tools for identification of neonatal hearing impairment. Design: A total of 4911 infants including 4478 graduates of neonatal intens ive care units, 353 well babies with one or more risk factors for hearing l oss (Joint Committee on Infant Hearing, 1994) and 80 well babies without ri sk factor who did not pass one or more neonatal test were targeted as the p otential subject pool on which test performance would be assessed. During t he neonatal period, they were evaluated using TEOAEs in response to an 80 d B pSPL click, DPOAE responses to two stimulus conditions (L1 = L2 = 75 dB S PL and L1 = 65 dB SPL L2 = 50 dE SPL), and ABR elicited by a 30 dB nHL, cli ck. In an effort to describe test performance, these "at-risk" infants were asked to return for behavioral audiologic assessments, using visual reinfo rcement audiometry (VRA) at 8 to 12 mo corrected age, regardless of neonata l test results. Sixty-four percent of these subjects returned and reliable VRA data were obtained on 95.6% of these returnees. This approach is in con trast to previous studies in which, by necessity, efforts were made to foll ow only those infants who "failed" the neonatal screening tests. The accura cy of the neonatal measures in predicting hearing status at 8 to 12 mo corr ected age was determined. Only those infants who provided reliable, monaura l VRA test results were included in the analysis. Separate analyses were pe rformed without regard to intercurrent events (i.e., events between the neo natal and VRA tests that could cause their results to disagree), and then a fter accounting for the possible influence of intercurrent events such as o titis media and late-onset or progressive hearing loss. Results: Low refer rates were achieved for the stopping criteria used in th e present study, especially when a protocol similar to the one recommended in the National Institutes of Health (1993) Consensus Conference Report was followed. These analyses, however, do not completely describe test perform ance because they did not compare neonatal screening test results with a go ld standard test of hearing. Test performance, as measured by the area unde r a relative operating characteristic curve, were similar for all three neo natal tests when neonatal test results were compared with VRA data obtained at 8 to 12 mo corrected age. However, ABRs were more successful at determi ning auditory status at 1 kHz, compared with the otoacoustic emission (OAE) tests. Performance was more similar across all three tests when they were used to identify hearing loss at 2 and 4 kHz. No test performed perfectly. Using either the two- or three-frequency pure-tone average (PTA), with a fi xed false alarm rate of 20%, hit rates for the neonatal tests, in general, exceeded 80% when hearing impairment was defined as behavioral thresholds g reater than or equal to 30 dB HL. All three tests performed similarly when a two-frequency (2 and 4 kHz) PTA was used as the gold standard; OAE test p erformance decreased when a three-frequency PTA (adding 1 kHz) was used as the gold standard definition. For both PTA. and all three neonatal screenin g measures, however, hit rate increased as the magnitude of hearing loss in creased. Conclusions: Singly, all three neonatal hearing screening tests resulted in low refer rates, especially if referrals for follow-up were made only for the cases in which stopping criteria were not met in both ears. Following a protocol similar to that recommended in the National Institutes of Health (1993) Consensus Conference report resulted in refer rates that were less t han 4%. TEOAEs at 80 dB pSPL, DPOAE at L1 = 65, L2 = 50 dB SPL and ABR at 3 0 dB nHL measured during the neonatal period, and as implemented in the cur rent study, performed similarly at predicting behavioral hearing status at 8 to 12 mo corrected age. Although perfect test performance was never achie ved, sensitivity for each measure increased with the magnitude of hearing l oss. This latter finding is important because it suggests that all three te sts performed better at identifying hearing losses for which intervention w ould be immediately recommended.